相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Genetic testing for RAD51C mutations: in the clinic and community
V. Sopik et al.
CLINICAL GENETICS (2015)
Society of Gynecologic Oncology statement on risk assessment for inherited gynecologic cancer predispositions
Johnathan M. Lancaster et al.
GYNECOLOGIC ONCOLOGY (2015)
Inherited Mutations in 17 Breast Cancer Susceptibility Genes Among a Large Triple-Negative Breast Cancer Cohort Unselected for Family History of Breast Cancer
Fergus J. Couch et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Prevalence of BRCA1 and BRCA2 mutations in unselected breast cancer patients from Peru
J. Abugattas et al.
CLINICAL GENETICS (2015)
Germline and Somatic Mutations in Homologous Recombination Genes Predict Platinum Response and Survival in Ovarian, Fallopian Tube, and Peritoneal Carcinomas
Kathryn P. Pennington et al.
CLINICAL CANCER RESEARCH (2014)
A new scoring system in cancer genetics: application to criteria for BRCA1 and BRCA2 mutation screening
Bernard Bonaiti et al.
JOURNAL OF MEDICAL GENETICS (2014)
Phase I/Ib Study of Olaparib and Carboplatin in BRCA1 or BRCA2 Mutation-Associated Breast or Ovarian Cancer With Biomarker Analyses
Jung-Min Lee et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2014)
Olaparib maintenance therapy in patients with platinum-sensitive relapsed serous ovarian cancer: a preplanned retrospective analysis of outcomes by BRCA status in a randomised phase 2 trial
Jonathan Ledermann et al.
LANCET ONCOLOGY (2014)
An association between the-41657 C/T polymorphism of X-ray repair cross-complementing 2 (XRCC2) gene and ovarian cancer
Magdalena M. Michalska et al.
MEDICAL ONCOLOGY (2014)
Breast-Cancer Risk in Families with Mutations in PALB2
A. C. Antoniou et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Integrated analysis of germline and somatic variants in ovarian cancer
Krishna L. Kanchi et al.
NATURE COMMUNICATIONS (2014)
Clinical Characteristics of Ovarian Cancer Classified by BRCA1, BRCA2, and RAD51C Status
J. M. Cunningham et al.
SCIENTIFIC REPORTS (2014)
Prevalence of BRCA1 and BRCA2 mutations in unselected breast cancer patients from medellin, Colombia
Julian Esteban Londono Hernandez et al.
HEREDITARY CANCER IN CLINICAL PRACTICE (2014)
Germline mutation in the RAD51B gene confers predisposition to breast cancer
Lisa Golmard et al.
BMC CANCER (2013)
The impact of next generation sequencing on the analysis of breast cancer susceptibility: a role for extremely rare genetic variation?
F. S. M. Hilbers et al.
CLINICAL GENETICS (2013)
Further evidence for the contribution of the BRCA1-interacting protein-terminal helicase 1 (BRIP1) gene in breast cancer susceptibility
L. P. Ren et al.
GENETICS AND MOLECULAR RESEARCH (2013)
Cancer Risks for BRCA1 and BRCA2 Mutation Carriers: Results From Prospective Analysis of EMBRACE
Nasim Mavaddat et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2013)
Rare Mutations in XRCC2 Increase the Risk of Breast Cancer
D. J. Park et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2012)
Patterns of genomic loss of heterozygosity predict homologous recombination repair defects in epithelial ovarian cancer
V. Abkevich et al.
BRITISH JOURNAL OF CANCER (2012)
Ploidy and Large-Scale Genomic Instability Consistently Identify Basal-like Breast Carcinomas with BRCA1/2 Inactivation
Tatiana Popova et al.
CANCER RESEARCH (2012)
BRCA1 and BRCA2 mutations among ovarian cancer patients from Colombia
Alexandra Ortiz Rodriguez et al.
GYNECOLOGIC ONCOLOGY (2012)
BRCA Mutation Frequency and Patterns of Treatment Response in BRCA Mutation-Positive Women With Ovarian Cancer: A Report From the Australian Ovarian Cancer Study Group
Kathryn Alsop et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Playing the End Game: DNA Double-Strand Break Repair Pathway Choice
J. Ross Chapman et al.
MOLECULAR CELL (2012)
Telomeric Allelic Imbalance Indicates Defective DNA Repair and Sensitivity to DNA-Damaging Agents
Nicolai J. Birkbak et al.
CANCER DISCOVERY (2012)
Hereditary breast cancer: clinical features and risk reduction strategies
A. Paradiso et al.
ANNALS OF ONCOLOGY (2011)
Family history, BRCA mutations and breast cancer in Vietnamese women
O. M. Ginsburg et al.
CLINICAL GENETICS (2011)
Integrated genomic analyses of ovarian carcinoma
D. Bell et al.
NATURE (2011)
Germline mutations in RAD51D confer susceptibility to ovarian cancer
Chey Loveday et al.
NATURE GENETICS (2011)
Prevalence of BRCA1 and BRCA2 mutations in unselected breast cancer patients from Greece
Chrissovaladis Koumpis et al.
HEREDITARY CANCER IN CLINICAL PRACTICE (2011)
Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial
Andrew Tutt et al.
LANCET (2010)
Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial
M. William Audeh et al.
LANCET (2010)
Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene
Alfons Meindl et al.
NATURE GENETICS (2010)
Addition of pathology and biomarker information significantly improves the performance of the Manchester scoring system for BRCA1 and BRCA2 testing
D. G. R. Evans et al.
JOURNAL OF MEDICAL GENETICS (2009)
PALB2 is an integral component of the BRCA complex required for homologous recombination repair
Shirley M. H. Sy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Expression of estrogen receptor beta in the breast carcinoma of BRCA1 mutation carriers
Maria M. Litwiniuk et al.
BMC CANCER (2008)
DNA repair by nonhomologous end joining and homologous recombination during cell cycle in human cells
Zhiyong Mao et al.
CELL CYCLE (2008)
BRCA1 and BRCA2 mutation prevalence and clinical characteristics of a population-based series of ovarian cancer cases from Denmark
Marie Soegaard et al.
CLINICAL CANCER RESEARCH (2008)
Selective inhibition of BRCA2-deficient mammary tumor cell growth by AZD2281 and cisplatin
Bastiaan Evers et al.
CLINICAL CANCER RESEARCH (2008)
High frequency of BRCA1/2 germline mutations in consecutive ovarian cancer patients in Poland
Izabela Brozek et al.
GYNECOLOGIC ONCOLOGY (2008)
Clinical and pathologic characteristics of patients with BRCA-positive and BRCA-negative breast cancer
Deann P. Atchley et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
High sensitivity of BRCA1-deficient mammary tumors to the PARP inhibitor AZD2281 alone and in combination with platinum drugs
Sven Rottenberg et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Meta-analysis of BRCA1 and BRCA2 penetrance
Sining Chen et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Prediction of BRCA1/2 mutation status in patients with ovarian cancer from a hospital-based cohort
Catharina E. Jacobi et al.
GENETICS IN MEDICINE (2007)
Biallelic mutations in PALB2 cause Fanconi anemia subtype FA-N and predispose to childhood cancer
Sarah Reid et al.
NATURE GENETICS (2007)
PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene
Nazneen Rahman et al.
NATURE GENETICS (2007)
Breast cancer risk-assessment models
D. Gareth R. Evans et al.
BREAST CANCER RESEARCH (2007)
Locoregional relapse and distant metastasis in conservatively managed triple negative early-stage breast cancer
Bruce G. Haffty et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: A kin-cohort study in Ontario, Canada
Harvey A. Risch et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
Truncating mutations in the Fanconi anemia J gene BRIP1 are low-penetrance breast cancer susceptibility alleles
Sheila Seal et al.
NATURE GENETICS (2006)
The roles of BRCA1 and BRCA2 and associated proteins in the maintenance of genomic stability
K. Gudmundsdottir et al.
ONCOGENE (2006)
Deficiency in the repair of DNA damage by homologous recombination and sensitivity to poly(ADP-ribose) polymerase inhibition
Nuala McCabe et al.
CANCER RESEARCH (2006)
ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles
Anthony Renwick et al.
NATURE GENETICS (2006)
The DNA helicase BRIP1 is defective in Fanconi anemia complementation group J
M Levitus et al.
NATURE GENETICS (2005)
Update on the Manchester scoring system for BRCA1 and BRCA2 testing -: art. no. e39
DGR Evans et al.
JOURNAL OF MEDICAL GENETICS (2005)
Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase
HE Bryant et al.
NATURE (2005)
Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy
H Farmer et al.
NATURE (2005)
Prevalence of BRCA1 and BRCA2 mutations in Korean breast cancer patients
SH Ahn et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2004)
One in 10 ovarian cancer patients carry germ line BRCA1 or BRCA2 mutations:: results of a prospective study in Southern Sweden
S Malander et al.
EUROPEAN JOURNAL OF CANCER (2004)
A new scoring system for the chances of identifying a BRCA1/2 mutation outperforms existing models including BRCAPRO
DGR Evans et al.
JOURNAL OF MEDICAL GENETICS (2004)
Hallmarks of 'BRCAness' in sporadic cancers
N Turner et al.
NATURE REVIEWS CANCER (2004)
Hereditary ovarian cancer in Poland
J Menkiszak et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history:: A combined analysis of 22 studies
A Antoniou et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2003)
Biallelic inactivation of BRCA2 in Fanconi anemia
NG Howlett et al.
SCIENCE (2002)
Oncogenic tyrosine kinases and the DNA-damage response
T Skorski
NATURE REVIEWS CANCER (2002)
BRCA1 and BRCA2 mutations among breast cancer patients from the Philippines
MLD Matsuda et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
Cancer susceptibility and the functions of BRCA1 and BRCA2
AR Venkitaraman
CELL (2002)
DNA methylation patterns in hereditary human cancers mimic sporadic tumorigenesis
M Esteller et al.
HUMAN MOLECULAR GENETICS (2001)
Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer
HA Risch et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2001)
分享论文
